USE OF EPITHELIAL MEMBRANE PROTEIN 2 [EMP2] TARGETING AGENTS IN TREATING LUNG DISORDERS
US Patent 11,890,340
Filed on 2020-10-29
Filed on 2020-10-29
COMPOSITIONS AND METHODS FOR INHIBITING HIV-1 REVERSE TRANSCRIPTASE
US Application 16/637,092
Filed on 2020-02-06
Filed on 2020-02-06
Novel Strategy For Inhibiting HIV-1 Reverse Transcriptase
Israel
272409
Filed on 2018-08-08
272409
Filed on 2018-08-08
COMPOSITIONS AND METHODS FOR INHIBITING HIV-1
REVERSE TRANSCRIPTASE
European Patent
18766424.8
Filed on 2018-08-08
18766424.8
Filed on 2018-08-08
COMPOSITIONS AND METHODS FOR INHIBITING HIV-1
REVERSE TRANSCRIPTASE
China
2018800636827
Filed on 2018-08-08
2018800636827
Filed on 2018-08-08
Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same
Australia
45303/96
Filed on 1995-12-28
45303/96
Filed on 1995-12-28
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
United Kingdom
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
France
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
Germany
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
Patent Cooperation Treaty
PCT/US2019/29801
Filed on 2019-04-30
PCT/US2019/29801
Filed on 2019-04-30